PG
ACGL icon

Prostatis Group’s Arch Capital ACGL Stock Holding History

Prostatis Group’s Portfolio ACGL Stock Details ACGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$200K Buy
+2,064
New +$195K 0.05% 189

Other funds holding ACGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Prostatis Group's ACGL Position: Q2 2026 in Review

Prostatis Group opened a new position in Arch Capital (ACGL) in Q2 2026: 2,064 shares worth $200K. The stake represents 0.05% of the portfolio and ranks #189 among its holdings.

906 funds tracked by Wall St. Rank hold ACGL as of Q2 2026.

  • Prostatis Group held 2,064 shares of Arch Capital worth $200K as of Q2 2026.
  • Arch Capital was a new Prostatis Group position in Q2 2026.
  • Arch Capital made up 0.05% of Prostatis Group's portfolio in Q2 2026, its #189 holding.
  • 906 funds tracked by Wall St. Rank held Arch Capital as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.